Glutathione determines chronic myeloid leukemia vulnerability to an inhibitor of CMPK and TMPK.
Saved in:
| Title: | Glutathione determines chronic myeloid leukemia vulnerability to an inhibitor of CMPK and TMPK. |
|---|---|
| Authors: | Huang, Chang-Yu1 (AUTHOR), Chung, Yin-Hsuan1 (AUTHOR), Wu, Sheng-Yang1 (AUTHOR), Wang, Hsin-Yen1 (AUTHOR), Lin, Chih-Yu2 (AUTHOR), Yang, Tsung-Jung3 (AUTHOR), Fang, Jim-Min3 (AUTHOR), Hu, Chun-Mei4 (AUTHOR), Chang, Zee-Fen1,5 (AUTHOR) zfchang@ntu.edu.tw |
| Source: | Communications Biology. 7/10/2024, Vol. 7 Issue 1, p1-13. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
